Antiplatelet Therapy for AIS Patients With Thrombocytopenia
Status:
Recruiting
Trial end date:
2026-01-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to test the safety and effectiveness of antiplatelet
therapy in acute ischemic stroke (AIS) patients with thrombocytopenia. Participants will be
prescribed antiplatelet agents and followed up for 3 months.
Phase:
N/A
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University